Arene Life Sciences (Unit 3) Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 10.83 Cr
as on 16-11-2024
- Company Age 18 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 123.10 Cr
as on 16-11-2024
- Satisfied Charges ₹ 43.00 Cr
as on 16-11-2024
- Revenue 2.87%
(FY 2023)
- Profit -36.63%
(FY 2023)
- Ebitda -27.81%
(FY 2023)
- Net Worth 14.50%
(FY 2023)
- Total Assets 29.63%
(FY 2023)
About Arene Life Sciences (Unit 3)
The Corporate was formerly known as A V R Organics Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 10.83 Cr.
The company currently has active open charges totaling ₹123.10 Cr. The company has closed loans amounting to ₹43.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Arene Life Sciences (Unit 3) Private Limited India is Sivanaga Vallakati as COMPANY SECRETARY. Satyanarayana Khairtabad, Satyanarayana Chinnamail, Khairtabad Reddy, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239TG2006PTC049202
- Company No.
049202
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Feb 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Arene Life Sciences (Unit 3)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sivanaga Vallakati | Company Secretary | 01-Apr-2023 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Chinnamail  | Director | 19-Feb-2020 | Current |
| Satyanarayana Khairtabad | Director | 02-Sep-2017 | Current |
| Satyanarayana Chinnamail | Director | 02-Sep-2017 | Current |
| Khairtabad Reddy | Director | 19-Feb-2020 | Current |
| Purushotam Angalagutha | Director | 04-Jan-2018 | Current |
Financial Performance and Corporate Structure Insights of Arene Life Sciences (Unit 3).
Arene Life Sciences (Unit 3) Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.87% increase. The company also saw a substantial fall in profitability, with a 36.63% decrease in profit. The company's net worth Soared by an impressive increase of 14.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arene Life Sciences (Unit 3)?
In 2023, Arene Life Sciences (Unit 3) had a promoter holding of 73.71% and a public holding of 26.29%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
S.R. Drugs And Intermediates Pvt.Ltd.Active 32 years 2 monthsSatyanarayana Khairtabad and Satyanarayana Chinnamail are mutual person
- S.R. Drugs And Intermediates (Unit 3) Private LimitedActive 4 years 6 months
Satyanarayana Khairtabad and Satyanarayana Chinnamail are mutual person
- S.R. Drugs And Intermediates (Unit 2) Private LimitedActive 4 years 6 months
Satyanarayana Khairtabad and Satyanarayana Chinnamail are mutual person
Arene Life Sciences Private LimitedActive 20 years 3 monthsSatyanarayana Khairtabad, Satyanarayana Chinnamail and 2 more are mutual person
- Arene Life Sciences (Unit 4) Private LimitedActive 3 years 7 months
Satyanarayana Khairtabad and Satyanarayana Chinnamail are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Karnataka Bank Ltd. Creation Date: 30 Dec 2021 | ₹8.90 Cr | Open |
Hdfc Bank Limited Creation Date: 24 Sep 2021 | ₹66.00 Cr | Open |
Karnataka Bank Ltd. Creation Date: 21 Apr 2020 | ₹48.20 Cr | Open |
How Many Employees Work at Arene Life Sciences (Unit 3)?
Arene Life Sciences (Unit 3) has a workforce of 368 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arene Life Sciences (Unit 3), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arene Life Sciences (Unit 3)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
